PlainRecalls
FDA Drug Moderate Class II Terminated

Valsartan/HCTZ 320/25mg Tablets, 30-count jar, Rx Only, Packaged by NuCare Pharmaceuticals, Inc., Orange, CA 92867, NDC 68071-4183-3

Reported: August 15, 2018 Initiated: July 30, 2018 #D-1039-2018

Product Description

Valsartan/HCTZ 320/25mg Tablets, 30-count jar, Rx Only, Packaged by NuCare Pharmaceuticals, Inc., Orange, CA 92867, NDC 68071-4183-3

Reason for Recall

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Details

Units Affected
N/A
Distribution
Distributed to three customers in Fl and CA
Location
Orange, CA

Frequently Asked Questions

What product was recalled?
Valsartan/HCTZ 320/25mg Tablets, 30-count jar, Rx Only, Packaged by NuCare Pharmaceuticals, Inc., Orange, CA 92867, NDC 68071-4183-3. Recalled by NuCare Pharmaceuticals Inc. Units affected: N/A.
Why was this product recalled?
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 15, 2018. Severity: Moderate. Recall number: D-1039-2018.